Thymidine Kinase 1 in the study of solid tumors

Thymidine Kinase 1 (TK1) has been long known as a valuable biomarker of cellular proliferation. However, previous methods have been based on enzyme activity measurements that may be subject to interference and may underestimate the forms of TK1 found in the serum of subjects with solid tumors

The AroCell TK 210 ELISA is a new valuable biomarker for studying the rate of proliferation and cell turnover of solid tumors. It brings the specificity of immunoassay to this field and offers improved accuracy when studying serum TK1 derived from patients with solid tumors.

The AroCell TK 210 ELISA test will provide new opportunities for studying cellular proliferation, tumor cell turnover and therapy response in subjects with solid tumors.

White paper_Study in Solid Tumors_20170828

Webinar TK 210 ELISA in Solid Tumors March 2017